A Relative Bioavailability and Food Effect Study of HDM1002 in Healthy Subjects

Phase 1 Not yet recruiting 33 enrolled Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.

RandomizedCrossoverOpen-labelTreatment

Summary

The main purpose of this study is to evaluate the effect of formulation on relative bioavailability of HDM1002, and the food effect on pharmacokinetics of HDM1002.

Timeline

Start: 2024-10
Primary completion: 2024-11
Completion: 2024-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HDM1002	Unknown	200 mg	Oral

Indications

No indication recorded.